Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir in HBV-related HCC after TACE
NCT01872988Phase 3Terminated
- Sponsor
- Taichung Veterans General Hospital
- Start
- Sep 2012
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate in hepatocellular carcinoma (HCC), Chronic Hepatitis B (CHB), sponsored by Taichung Veterans General Hospital. Started Sep 2012; status: terminated.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatocellular carcinoma (HCC)Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01872988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01872988.